DRES-08. CLINICAL SIGNIFICANCE OF HYPERMUTATION IN GLIOMAS

BACKGROUND: Hypermutation is an emerging biomarker for predicting response to immunotherapy in cancer patients, however its clinical value in gliomas is not established. We sought to assess the determinants of hypermutation in gliomas, and its value for predicting response to standard of care and im...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Touat, Mehdi, Li, Yvonne, Boynton, Adam, Spurr, Liam, Iorgulescu, Bryan, Birzu, Christina, Pal, Sangita, Ferrer-Luna, Ruben, Geduldig, Jack, Bellamy, Charlotte, Younan, Nadia, Baldini, Capucine, Verreault, Maite, Guillerm, Erell, Ammari, Samy, Beuvon, Frederic, Mokhtari, Karima, Alentorn, Agusti, Dehais, Caroline, Houiller, Caroline, Laigle-Donadey, Florence, Lee, Eudocia, Nayak, Lakshmi, Carpentier, Alexandre, Cornu, Philippe, mathon, Bertrand, Bi, Wenya, Chiocca, Ennio, Alexandrescu, Sanda, Chi, Susan, Haas-Kogan, Daphne, Alexander, Brian, Huang, Raymond, Ligon, Azra, Coulet, Florence, Delattre, Jean-Yves, Hoang-Xuan, Khe, Meredith, David, Santagata, Sandro, Duval, Alex, Sanson, Marc, Cherniack, Andrew, Wen, Patrick, Reardon, David, Marabelle, Aurelien, Idbaih, Ahmed, Beroukhim, Rameen, Bandopadhayay, Pratiti, Bielle, Franck, Ligon, Keith
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Drug Resistance
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847135/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.296
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller